Patients with DM were found to have a significant reduction in the levels of GLP-1, which is believed to occur due to a reduction in the expression of GLP-1 receptors in the pancreas [112,113] or an enhancement of DPP-4 activity [113]. Here, GLP1R is linked to diabetes mellitus.